Book chapter · 2008

Peptide-Based Drug Design: Here and Now

Laszlo Jr Otvos

Methods in molecular biology, 494, 1–8 · Published 1 January 2008 · DOI 10.1007/978-1-59745-419-3_1

View at the publisherCite this paper

In brief

“Peptide-Based Drug Design: Here and Now” is a 2008 book chapter by Laszlo Jr Otvos, published in Methods in molecular biology. OpenAlex counts 128 citations as of 15 November 2026, which puts it in the top 5% of works published in 2008 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
128
Most cited in
2022 (10)
Field-weighted impact
92.79
References
30
Authors
1

Abstract

After many years of stagnation, peptide therapeutics once again became the focus of innovative drug development efforts backed up by venture funds and biotechnology companies. Designer peptide drugs overcome the unattractive pharmacological properties of native peptides and protein fragments and frequently feature nonnatural amino acid or backbone replacements, cyclic or multimeric structures, or peptidic or… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Otvos, L. J. (2008). Peptide-Based Drug Design: Here and Now. Methods in molecular biology, 494, 1–8. https://doi.org/10.1007/978-1-59745-419-3_1

MLA 9

Otvos, Laszlo Jr. “Peptide-Based Drug Design: Here and Now.” Methods in molecular biology, vol. 494, 2008, pp. 1–8. https://doi.org/10.1007/978-1-59745-419-3_1.

Chicago

Otvos, Laszlo Jr. 2008. “Peptide-Based Drug Design: Here and Now.” Methods in molecular biology 494: 1–8. https://doi.org/10.1007/978-1-59745-419-3_1.

Harvard

Otvos, L. J. (2008) ‘Peptide-Based Drug Design: Here and Now’, Methods in molecular biology, 494, pp. 1–8. doi:10.1007/978-1-59745-419-3_1.

IEEE

L. J. Otvos, “Peptide-Based Drug Design: Here and Now,” Methods in molecular biology, vol. 494, pp. 1–8, 2008, doi: 10.1007/978-1-59745-419-3_1.

BibTeX

@incollection{otvos2008peptide,
  title     = {{Peptide-Based Drug Design: Here and Now}},
  author    = {Otvos, Laszlo Jr},
  booktitle = {Methods in molecular biology},
  publisher = {Springer Science+Business Media},
  year      = {2008},
  volume    = {494},
  pages     = {1--8},
  doi       = {10.1007/978-1-59745-419-3_1},
  url       = {https://doi.org/10.1007/978-1-59745-419-3_1}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201744
201855
201988
202055
202188
20221010
202377
202433
202599
202633

Its field-weighted citation impact is 92.79: it has been cited 92.79 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis

  • peptide therapeutics
  • peptide drug design
  • unnatural amino acids
  • cyclic peptides
  • peptide vaccine
  • antibacterial peptides
  • HIV
  • cancer

Work with this paper

Most-cited papers in Chemistry

All highly cited Chemistry papers

Questions about this paper

How do I cite this paper in APA style?

Otvos, L. J. (2008). Peptide-Based Drug Design: Here and Now. Methods in molecular biology, 494, 1–8. https://doi.org/10.1007/978-1-59745-419-3_1

How many times has this paper been cited?

128 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Laszlo Jr Otvos.

What is the DOI of this paper?

10.1007/978-1-59745-419-3_1. The permanent link is https://doi.org/10.1007/978-1-59745-419-3_1.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.